| Gaye C Beatty, LCSW | |
|
501 N 17th St, Suite 214, Allentown, PA 18104-5044 | |
| (610) 434-0962 | |
| (610) 434-1574 |
| Full Name | Gaye C Beatty |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 501 N 17th St, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932109436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | CW001507-L (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gaye C Beatty, LCSW 501 N 17th St, Suite 214, Allentown, PA 18104-5044 Ph: (610) 434-0962 | Gaye C Beatty, LCSW 501 N 17th St, Suite 214, Allentown, PA 18104-5044 Ph: (610) 434-0962 |
News Archive
Kareus Therapeutics SA, the private biotechnology company focused on the development of novel therapeutics for the unmet treatment of age-related and chronic diseases, today announces the start of a Phase I clinical study following the Investigational New Drug (IND) approval from the US Food and Drug Administration for the development of KU-046, a first-in-class disease modifying new chemical entity discovered for the treatment of Alzheimer's disease using Kareus' proprietary bioenergetics and KARLECT platforms.
Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 "priority pathogens" recently defined by the World Health Organization as antiobiotic-resistant bacteria requiring new interventions.
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy.
Caring for a patient with sepsis requires walking a treatment tightrope. Clinicians must identify the pathogen that is causing a patient's infection, carefully monitor the patient's response to antibiotics and supportive measures and race against the clock to prevent potential organ failure and death.
› Verified 3 days ago
Sarah A Miller, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 530 N 7th St, Allentown, PA 18102 Phone: 484-221-9136 Fax: 484-221-9130 | |
Lauren Stutts, MSS, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1919 W Livingston St, Allentown, PA 18104 Phone: 484-695-7994 | |
Mrs. Lucia Alexandra Cortes, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2020 Lawfer Ave, Allentown, PA 18104 Phone: 484-273-0194 | |
Dale James Ezrow, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1259 S Cedar Crest Blvd Ste 230, Allentown, PA 18103 Phone: 610-402-5900 Fax: 610-402-4650 | |
Monica R Johnson, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 5000 W Tilghman St, Allentown, PA 18104 Phone: 484-352-2794 | |
Mr. Kevin Lee Moore, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1728 Jonathan St, Suite 200, Allentown, PA 13104 Phone: 610-433-8550 Fax: 610-433-4488 | |
Ms. Susan Fiske, MSW,LCSW,BCD Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1405 N Cedar Crest Blvd, Suite 115, Allentown, PA 18104 Phone: 610-432-0509 |